封面
市场调查报告书
商品编码
1733943

全球子宫切除器械市场

Hysterectomy Devices

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 381 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球子宫切除器械市场规模将达到 4.547 亿美元

2024 年全球子宫切除器械市场规模估计为 3.754 亿美元,预计到 2030 年将达到 4.547 亿美元,在 2024-2030 年分析期内的复合年增长率为 3.2%。腹腔镜子宫切除术是报告中分析的一个领域,预计其复合年增长率为 2.8%,到分析期结束时将达到 2.01 亿美元。在分析期内,机器人辅助腹腔镜子宫切除术部分的成长率估计为 2.9%。

美国市场规模估计为 1.023 亿美元,中国市场预计复合年增长率为 6.0%

预计 2024 年美国子宫切除器械市场价值将达到 1.023 亿美元。预计到 2030 年,世界第二大经济体中国市场规模将达到 8,940 万美元,在 2024-2030 年分析期间的复合年增长率为 6.0%。其他值得注意的区域市场包括日本和加拿大,预计在分析期间的复合年增长率分别为 1.3% 和 2.5%。在欧洲,德国的复合年增长率预计为 1.8%。

全球子宫切除器械市场-主要趋势与驱动因素摘要

为什么子宫切除器械在现代妇科手术中很重要?

子宫切除术(以手术切除子宫)是女性健康中最常见的手术之一,主要用于治疗子宫肌瘤、异常出血、子宫内膜异位症、子宫癌和骨盆器官脱垂等疾病。子宫切除术器械透过最大限度地减少手术创伤、减少失血、提高手术速度和准确性,在改善手术结果方面发挥关键作用。这些设备包括用于开放式和微创方法的电外科器械、碎切器、子宫操作器和腹腔镜工具。

腹腔镜、机器人辅助和阴道子宫切除等微创手术的转变正在推动先进子宫切除术设备平台的采用。微创手术(MIS)因其恢復时间短、併发症发生率低、美观效果好而受到青睐。医院和门诊手术中心正在加大对这些设备的投资,以符合增强的復健通讯协定和注重患者满意度和成本效益的基于价值的护理计划。

哪些设备创新使得子宫切除手术更安全、准确?

子宫切除术器械的技术进步主要集中在改善手术控制、降低术中风险和促进复杂的解剖入路。双极和超音波能量仪器已取代传统的单极仪器进行血管封闭和组织解剖,从而减少热损伤并加快止血速度。新一代的碎切器采用密封系统设计,以最大限度地降低腹腔镜手术期间组织接种的风险,特别是考虑到未确诊恶性肿瘤的规定。

机器人辅助子宫切除术也是一个创新领域,製造商引入多关节器械和AI增强运动控制系统来支援复杂的妇科手术。增强型子宫操纵器具有可调节定位和符合人体工学的控制功能,也提高了手术的可视化和可及性。此外,单孔和微型腹腔镜设备扩大了微创途径,为传统多孔手术提供了可行的替代方案。总的来说,这些创新支持更安全、更快捷、更以病人为中心的妇科手术。

哪些医疗环境和地区正在推动子宫切除设备的需求?

医院、门诊手术中心和专科妇科诊所是子宫切除器械的主要最终使用者。门诊和当日手术的趋势正在推动对微创设备套件和基于能量的仪器的需求。外科医生越来越多地采用先进的平台来减少併发症并加快术后出院速度。

由于妇科选择性手术数量众多、报销政策优惠以及机器人辅助平台的广泛采用,北美在市场上占据主导地位。欧洲紧随其后,拥有强大的腹腔镜专业知识和外科创新基础。由于人们对微创手术选择的认识不断提高、手术基础设施不断改善以及妇科护理方面未满足的需求很高,亚太地区正在经历快速增长。在新兴国家,官民合作关係和医疗旅游进一步加速了子宫切除设备的采用。

子宫切除器械市场的成长受到多种因素的推动…

子宫切除术器械市场的成长受到多种因素的推动,例如子宫疾病发病率的上升、对微创和门诊手术的偏好增加以及基于能量的手术器械的进步。从技术上讲,双极密封系统、机器人平台和具有控制能力的碎切器的改进使得手术更加安全,并扩大了手术适应症。医院和门诊中心正在采用这些创新来缩短住院时间并改善病患的治疗效果。

从最终用途的角度来看,全球妇科手术数量的增加,特别是子宫肌瘤和子宫内膜异位症手术数量的增加,以及支持性报销框架和医生培训计划,正在推动需求。此外,新兴地区女性健康意识提升的宣传活动增强和外科治疗机会的增加也有助于扩大市场基础。随着医疗保健提供者寻求提供更安全、更有效的子宫切除术选择,设备创新和微创技术的采用将继续推动市场发展势头。

部分

手术方式(全腹腔镜子宫切除术、机器人辅助腹腔镜子宫切除术、全腹腔子宫切除术、全阴子宫切除术)、疾病类型(子宫癌、子宫肌瘤、慢性骨盆腔疼痛、其他疾病类型)、最终用户(医院、门诊手术中心、其他最终用户)

受访公司范例(总合42家公司)

  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Conkin Surgical Instrument Ltd.
  • CONMED Corporation
  • CooperSurgical Inc.
  • Fortimedix Surgical BV
  • Hologic, Inc.
  • Intuitive Surgical, Inc.
  • KARL STORZ GmbH & Co. KG
  • Laborie Medical Technologies Inc.
  • Medtronic plc
  • Minerva Surgical, Inc.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Stryker Corporation
  • Teleflex Incorporated
  • Utah Medical Products, Inc.
  • Uterine Manipulation Devices, Inc.
  • Zimmer Biomet Holdings, Inc.

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口(成品和OEM)预测公司竞争地位的变化。这种复杂且多方面的市场动态预计将以多种方式影响竞争对手,包括人为提高销货成本、降低盈利、重组供应链等微观和宏观市场动态。

全球产业分析师密切关注世界领先的首席经济学家(14,949)、智库(62)和贸易及产业协会(171)的专家意见,以评估生态系统的影响并应对新的市场现实。各主要国家的专家和经济学家都在关注关税及其对国家的影响。

全球产业分析师预计,这种动盪将在未来几个月内平息,新的世界秩序将更加明确地建立。全球产业分析师正在即时追踪这些发展。

2025年4月:谈判阶段

我们四月份的发布将涵盖关税对全球市场整体的影响,并为各地区的市场调整提供指导。我们的预测是基于历史数据和不断发展的市场影响因素。

2025年7月:最终关税调整

免费更新 在各国宣布最终重置后,本公司的客户将在 7 月收到免费更新。最终更新包含明确的关税影响分析。

相互和双边贸易及关税影响分析:

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家:全球产业分析师知识库追踪 14,949 位经济学家,其中包括来自民族国家、智库、贸易和产业协会、大型企业和领域专家的最具影响力的首席经济学家,他们共用了全球经济状况这一前所未有的模式转移的影响。我们的 16,491 多份报告中的大多数都遵循这个基于两阶段里程碑的发布计划。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP33955

Global Hysterectomy Devices Market to Reach US$454.7 Million by 2030

The global market for Hysterectomy Devices estimated at US$375.4 Million in the year 2024, is expected to reach US$454.7 Million by 2030, growing at a CAGR of 3.2% over the analysis period 2024-2030. Laparoscopic Hysterectomy, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$201.0 Million by the end of the analysis period. Growth in the Robotic Assisted Laparoscopic Hysterectomy segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$102.3 Million While China is Forecast to Grow at 6.0% CAGR

The Hysterectomy Devices market in the U.S. is estimated at US$102.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$89.4 Million by the year 2030 trailing a CAGR of 6.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Hysterectomy Devices Market - Key Trends & Drivers Summarized

Why Are Hysterectomy Devices Crucial in Modern Gynecological Surgery?

Hysterectomy-the surgical removal of the uterus-is one of the most frequently performed procedures in women’s health, primarily for treating conditions such as uterine fibroids, abnormal bleeding, endometriosis, uterine cancer, and pelvic organ prolapse. Hysterectomy devices play a vital role in improving surgical outcomes by minimizing operative trauma, reducing bleeding, and enhancing procedural speed and precision. These devices include electrosurgical instruments, morcellators, uterine manipulators, and laparoscopic tools, tailored for both open and minimally invasive approaches.

The shift toward less invasive techniques-such as laparoscopic, robotic-assisted, and vaginal hysterectomies-is driving the adoption of advanced hysterectomy device platforms. Minimally invasive surgeries (MIS) are preferred for their shorter recovery times, lower complication rates, and improved cosmetic outcomes. Hospitals and outpatient surgical centers are increasingly investing in these devices to align with enhanced recovery protocols and value-based care initiatives focused on patient satisfaction and cost-efficiency.

How Are Device Innovations Enhancing Safety and Precision in Hysterectomy Procedures?

Technology advancements in hysterectomy devices are centered on improving surgical control, reducing intraoperative risk, and facilitating complex anatomical access. Bipolar and ultrasonic energy-based instruments are replacing traditional monopolar tools for vessel sealing and tissue dissection, resulting in reduced thermal damage and faster hemostasis. New-generation morcellators are being designed with containment systems to minimize the risk of tissue dissemination during laparoscopic procedures-especially in light of regulatory scrutiny around undiagnosed malignancies.

Robotic-assisted hysterectomy is another innovation area, with manufacturers introducing articulated instruments and AI-enhanced motion control systems to support complex gynecologic procedures. Enhanced uterine manipulators with adjustable positioning and ergonomic controls are also improving procedural visualization and access. Additionally, single-port and mini-laparoscopy devices are expanding minimally invasive access, offering viable alternatives to traditional multi-port techniques. These innovations collectively support safer, faster, and more patient-centered gynecologic surgery.

Which Healthcare Settings and Regions Are Driving Hysterectomy Device Demand?

Hospitals, ambulatory surgical centers, and specialized gynecology clinics represent the primary end-users of hysterectomy devices. The trend toward outpatient and day-case surgeries is boosting the demand for minimally invasive device kits and energy-based instruments. Surgeons are increasingly adopting advanced platforms to reduce complications and enable quicker post-operative discharge, especially in health systems focused on bundled payment models and procedural efficiency.

North America dominates the market, driven by a high volume of elective gynecologic surgeries, favorable reimbursement policies, and widespread use of robotic-assisted platforms. Europe follows with a strong base of laparoscopic expertise and surgical innovation. The Asia-Pacific region is experiencing rapid growth due to rising awareness of minimally invasive options, increased surgical infrastructure, and a large unmet need for gynecologic care. In emerging economies, public-private partnerships and medical tourism are further accelerating hysterectomy device adoption.

The Growth in the Hysterectomy Devices Market Is Driven by Several Factors…

The growth in the hysterectomy devices market is driven by several factors including the rising incidence of uterine disorders, increasing preference for minimally invasive and outpatient surgical techniques, and advancements in energy-based surgical instruments. Technologically, improvements in bipolar sealing systems, robotic platforms, and containment-equipped morcellators are enhancing procedural safety and expanding surgical indications. Hospitals and ambulatory centers are adopting these innovations to reduce length of stay and improve patient outcomes.

From an end-use perspective, the global rise in gynecologic surgery volumes-particularly for fibroids and endometriosis-along with supportive reimbursement frameworks and physician training programs, is fueling demand. Additionally, the growth of women’s health awareness campaigns and expanding access to surgical care in emerging regions are broadening market reach. As healthcare providers seek to offer safer, more effective hysterectomy options, device innovation and minimally invasive adoption will continue to drive market momentum.

SCOPE OF STUDY:

The report analyzes the Hysterectomy Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Surgical Approach (Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy, Vaginal Hysterectomy); Disease Type (Uterine Cancer, Fibroids, Chronic Pelvic Pain, Other Disease Types); End-User (Hospitals, Ambulatory Surgery Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Conkin Surgical Instrument Ltd.
  • CONMED Corporation
  • CooperSurgical Inc.
  • Fortimedix Surgical B.V.
  • Hologic, Inc.
  • Intuitive Surgical, Inc.
  • KARL STORZ GmbH & Co. KG
  • Laborie Medical Technologies Inc.
  • Medtronic plc
  • Minerva Surgical, Inc.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Stryker Corporation
  • Teleflex Incorporated
  • Utah Medical Products, Inc.
  • Uterine Manipulation Devices, Inc.
  • Zimmer Biomet Holdings, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Hysterectomy Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Uterine Fibroids and Endometriosis Drives Global Demand for Hysterectomy Procedures
    • Technological Advancements in Laparoscopic and Robotic Hysterectomy Devices Enhance Surgical Precision
    • Increased Preference for Minimally Invasive Gynecologic Surgeries Fuels Demand for Advanced Energy Devices
    • Growth in Ambulatory Surgical Centers (ASCs) Accelerates Adoption of Compact, Single-Use Hysterectomy Tools
    • Patient Preference for Faster Recovery and Fewer Complications Supports Market Shift to Laparoscopic Systems
    • Hospital Cost Reduction Initiatives Encourage Procurement of Multifunctional, Reusable Devices
    • Robotic-Assisted Surgery Platforms Gain Traction for Complex and Repeat Hysterectomy Procedures
    • Growing Demand for Uterine-Sparing Techniques Drives Development of Targeted Tissue Removal Technologies
    • Regulatory Approvals of Advanced Morcellators and Electrosurgical Instruments Expand Product Portfolios
    • Improved Visualization Systems and Imaging-Guided Devices Enhance Surgeon Confidence and Outcomes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hysterectomy Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hysterectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hysterectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hysterectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Laparoscopic Hysterectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Laparoscopic Hysterectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Laparoscopic Hysterectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Robotic Assisted Laparoscopic Hysterectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Robotic Assisted Laparoscopic Hysterectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Robotic Assisted Laparoscopic Hysterectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Abdominal Hysterectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Abdominal Hysterectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Abdominal Hysterectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Vaginal Hysterectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Vaginal Hysterectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Vaginal Hysterectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Uterine Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Uterine Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Uterine Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Fibroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Fibroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Fibroids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Chronic Pelvic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Chronic Pelvic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Chronic Pelvic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Disease Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hysterectomy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Hysterectomy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • CHINA
    • Hysterectomy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Hysterectomy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Hysterectomy Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Hysterectomy Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Hysterectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Hysterectomy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Hysterectomy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hysterectomy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hysterectomy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Hysterectomy Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Hysterectomy Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Hysterectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hysterectomy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • INDIA
    • Hysterectomy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hysterectomy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Hysterectomy Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Hysterectomy Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Hysterectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hysterectomy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Hysterectomy Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Hysterectomy Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Hysterectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Hysterectomy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Hysterectomy Devices by Surgical Approach - Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Hysterectomy Devices by Surgical Approach - Percentage Breakdown of Value Sales for Laparoscopic Hysterectomy, Robotic Assisted Laparoscopic Hysterectomy, Abdominal Hysterectomy and Vaginal Hysterectomy for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Hysterectomy Devices by End-user - Ambulatory Surgery Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Hysterectomy Devices by End-user - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Hysterectomy Devices by Disease Type - Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Hysterectomy Devices by Disease Type - Percentage Breakdown of Value Sales for Uterine Cancer, Fibroids, Chronic Pelvic Pain and Other Disease Types for the Years 2015, 2025 & 2030

IV. COMPETITION